FourPoints Investment Managers’s Bioverativ Inc. Common Stock BIVV Stock Holding History

FourPoints Investment Managers’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$213K	Buy	+3,913	New	+$193K	0.22%	46

Other funds holding BIVV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

SIG

Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FourPoints Investment Managers's BIVV Position: Q1 2017 in Review

FourPoints Investment Managers opened a new position in Bioverativ Inc. Common Stock (BIVV) in Q1 2017: 3,913 shares worth $213K. The stake represents 0.22% of the portfolio and ranks #46 among its holdings.

467 funds tracked by Wall St. Rank hold BIVV as of Q1 2017.

FourPoints Investment Managers held 3,913 shares of Bioverativ Inc. Common Stock worth $213K as of Q1 2017.
Bioverativ Inc. Common Stock was a new FourPoints Investment Managers position in Q1 2017.
Bioverativ Inc. Common Stock made up 0.22% of FourPoints Investment Managers's portfolio in Q1 2017, its #46 holding.
467 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2017.

Based on FourPoints Investment Managers's 13F filing for Q1 2017, filed 15 May 2017.